Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of care in telehealth ketamine, making this a timely conversation about the opportunities and challenges in this growing industry.

In our discussion, Juan Pablo shares how his early experiences with Wachuma inspired his interest in psychedelics for mental health. We address key topics, including the potential for ketamine addiction, the impact of Matthew Perry’s death on the psychedelic community, and the surprising role of insurance companies in shaping telehealth standards. We also explore the Religious Freedom Restoration Act, Juan Pablo’s work with the Eagle Condor Church, and how integration is best approached as a community effort.

Juan Pablo is a seasoned entrepreneur who co-founded a leading Latin American crowdfunding platform and a creative campus in Miami’s Wynwood Arts District. As the former CEO of New Life Health, now part of Beckley Waves, he continues to engage in work that bridges innovation, care, and community in the psychedelic space.

Timestamps

  • (06:00) Juan Pablo’s background in Chile and his experience with Wachuma
  • (11:30) Why ketamine is used in mental health treatment
  • (21:00) Is ketamine addictive?
  • (25:00) Matthew Perry’s death as a wake-up call for the ketamine community
  • (36:00) The surprising regulatory influence of insurance companies
  • (41:00) The Religious Freedom Restoration Act and the Eagle Condor Church
  • (53:00) The lack of integration in traditional psychedelic therapy contexts
  • (57:00) Integration as a community-driven process


Links

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(64)

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...

21 Apr 1h 10min

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...

25 Apr 202555min

Joshua White: Who You Gonna Call? Fireside

Joshua White: Who You Gonna Call? Fireside

Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...

13 Feb 20251h 14min

Tom Feegel: Ibogaine for Cognitive Enhancement

Tom Feegel: Ibogaine for Cognitive Enhancement

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...

27 Jan 20251h 6min

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...

28 Okt 20241h 3min

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...

18 Okt 20241h 9min

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...

8 Aug 202446min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
bullfika
rss-vuxna-pa-latsas
inga-beiga-morsor
angestpodden
johannes-hansen-podcast
sexnoveller-deluxe
not-fanny-anymore
rss-viktmedicinpodden
sa-in-i-sjalen
rss-hos-psykologen
rss-autismandan
hacka-livet
tyngre-traningssnack
sova-med-dan-horning
rss-angra-inget-3
tyngre-radio
halsoveckan-by-tyngre
rss-paus-guidade-meditationer